Analysen von Richard Vosser
| 14:06 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 23.01.26 | Bayer Overweight | JP Morgan Chase & Co. | |
| 19.01.26 | Merck Overweight | JP Morgan Chase & Co. | |
| 19.01.26 | Bayer Overweight | JP Morgan Chase & Co. | |
| 16.01.26 | Merck Overweight | JP Morgan Chase & Co. | |
| 15.01.26 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 15.01.26 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 06.01.26 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
|
Werbung
|
|||
| 05.01.26 | Novartis Overweight | JP Morgan Chase & Co. | |
| 05.01.26 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 23.12.25 | Novartis Overweight | JP Morgan Chase & Co. | |
| 18.12.25 | Merck Overweight | JP Morgan Chase & Co. | |
| 16.12.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 15.12.25 | Merck Overweight | JP Morgan Chase & Co. | |
| 15.12.25 | arGEN-X Overweight | JP Morgan Chase & Co. | |
| 15.12.25 | Sartorius Stedim Biotech Overweight | JP Morgan Chase & Co. | |
| 15.12.25 | Sartorius vz. Overweight | JP Morgan Chase & Co. | |
| 08.12.25 | Sartorius Stedim Biotech Overweight | JP Morgan Chase & Co. | |
| 08.12.25 | Sartorius vz. Overweight | JP Morgan Chase & Co. | |
| 08.12.25 | Merck Overweight | JP Morgan Chase & Co. | |
| 08.12.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 08.12.25 | Bayer Overweight | JP Morgan Chase & Co. | |
| 08.12.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 08.12.25 | Novartis Overweight | JP Morgan Chase & Co. | |
| 25.11.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 24.11.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 14.11.25 | Merck Overweight | JP Morgan Chase & Co. | |
| 13.11.25 | Merck Overweight | JP Morgan Chase & Co. | |
| 10.11.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 07.11.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 05.11.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 03.11.25 | Merck Overweight | JP Morgan Chase & Co. | |
| 30.10.25 | Merck Overweight | JP Morgan Chase & Co. | |
| 29.10.25 | Merck Overweight | JP Morgan Chase & Co. | |
| 24.10.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 24.10.25 | Sanofi Overweight | JP Morgan Chase & Co. | |
| 22.10.25 | Sanofi Overweight | JP Morgan Chase & Co. | |
| 20.10.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 17.10.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 17.10.25 | Sartorius vz. Overweight | JP Morgan Chase & Co. | |
| 17.10.25 | Merck Overweight | JP Morgan Chase & Co. | |
| 16.10.25 | Merck Overweight | JP Morgan Chase & Co. | |
| 16.10.25 | Sartorius Stedim Biotech Overweight | JP Morgan Chase & Co. | |
| 16.10.25 | Sartorius vz. Overweight | JP Morgan Chase & Co. | |
| 15.10.25 | Sanofi Overweight | JP Morgan Chase & Co. | |
| 13.10.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 09.10.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 07.10.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 06.10.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 06.10.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |